Sorafenib in Thyroid Cancer Patients: Learning From Toxicity In Reply

被引：0
|
作者：
Cabanillas, Maria E. [1 ]
Dadu, Ramona [1 ]
Lai, Stephen Y. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
来源：
ONCOLOGIST | 2014年 / 19卷 / 08期
关键词：
D O I：
10.1634/theoncologist.2014-0186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E4 / E4
页数：1
相关论文
共 50 条
  • [31] Asymptomatic Patients and Rising Incidence of Thyroid Cancer Reply
    Sajisevi, Mirabelle
    Davies, Louise
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (12) : 1186 - 1186
  • [32] Thyroid nodules and thyroid cancer - In reply
    Mackenzie, EJ
    Mortimer, RH
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (12) : 655 - 655
  • [33] Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
    Clemons, Julia
    Gao, Dexiang
    Naam, Mary
    Breaker, Kathryn
    Garfield, David
    Flaig, Thomas W.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 225 - 231
  • [34] Pancreatic Atrophy from Sorafenib REPLY
    Hescot, Segolene
    Vignaux, Olivier
    Goldwasser, Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (02): : 186 - 186
  • [35] Hematologic Toxicity in Patients Treated with Sunitinib for Advanced Thyroid Cancer
    Gkountouvas, Anastasios
    Kostoglou-Athanassiou, Ifigeneia
    Veniou, Eirini
    Repousis, Panagiotis
    Ziras, Nikolaos
    Kaldrimidis, Philippos
    THYROID, 2010, 20 (06) : 597 - 600
  • [36] Thyroid dysfunction in patients (pts) with metastatic renal cell cancer (RCC) treated with sorafenib
    Clement, P.
    Wolter, P.
    Stefan, C.
    Decallonne, B.
    Dumez, H.
    Wildiers, H.
    Schoffski, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Effect of BRAFV600E on response to sorafenib in advanced thyroid cancer patients
    Brose, M. S.
    Troxel, A. B.
    Redlinger, M.
    Harlacker, K.
    Redlinger, C.
    Chalian, A. A.
    Flaherty, K. T.
    Loevner, L. A.
    Mandel, S. J.
    O'Dwyer, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Effect of sorafenib in symptomatic metastatic medullary thyroid cancer
    Kober, F.
    Hermann, M.
    Handler, A.
    Krotla, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Phase II trial of sorafenib in advanced thyroid cancer
    Gupta-Abramson, Vandana
    Troxel, Andrea B.
    Nellore, Anoma
    Puttaswamy, Kanchan
    Redlinger, Maryann
    Ransone, Kathy
    Mandel, Susan J.
    Flaherty, Keith T.
    Loevner, Laurie A.
    O'Dwyer, Peter J.
    Brose, Marcia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4714 - 4719
  • [40] pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer
    Mark Yarchoan
    Changqing Ma
    Andrea B. Troxel
    Stephen J. Stopenski
    Waixing Tang
    Aaron B. Cohen
    Marina Pappas-Paxinos
    Burles A. Johnson
    Emerson Y. Chen
    Michael D. Feldman
    Marcia S. Brose
    Hormones and Cancer, 2016, 7 : 188 - 195
12345